Windward Bio is a startup based in Israel, most recent round Series A, 2 tracked investors.
Windward Bio is a company founded in 2024 headquartered in Israel. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Windward Bio is a clinical-stage biotechnology company developing long-acting monoclonal antibodies targeting TSLP and related pathways to treat serious immunological conditions such as asthma and COPD.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.